People

I study how innate immune cells sense danger and decide how to respond. I opened the Innate Immune Cell Biology Laboratory at GIMM in October 2026.

I trained in Molecular Medicine and Biochemistry at the University of Freiburg, with research in cell death signaling in Freiburg and at St. Jude Children's Research Hospital. For my PhD with Eva-Maria Frickel at the Francis Crick Institute and Imperial College London, I uncovered new functions of human guanylate-binding proteins in infection and cell death, and built HRMAn, an AI platform for analyzing host–pathogen images.

As a postdoc with Jonathan Kagan at Boston Children's Hospital and Harvard Medical School, I redefined how myddosomes execute Toll-like receptor signaling. At GIMM I bring together both lines of work with synthetic biology approaches that engineer signaling complexes.